Abstract
Structural modifications of CGS 26303, a non-peptidic α-aminophosphonate dual ECE/NEP inhibitor lead, were performed to maximize inhibition of recombinant human ECE-1, while maintaining strong NEP inhibition. Specifically, substitution of the α-aminophosphonate moiety with aryl ethyl side-chains led to the discovery of a new class of potent, non-peptidic, dual inhibitors, such as CGS 31447, which blocked ECE-1 and NEP activities with IC50's of 17 and 5 nM, respectively.
Cite
CITATION STYLE
De Lombaert, S., Stamford, L. B., Blanchard, L., Jenny, T., Hoyer, D., Clive, G., … Jeng, A. Y. (1997). Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11. Bioorganic and Medicinal Chemistry Letters, 7(8), 1059–1064. https://doi.org/10.1016/S0960-894X(97)00159-5
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.